Cargando…
Real-world effectiveness and tolerability of small-cell lung cancer (SCLC) treatments: A systematic literature review (SLR)
OBJECTIVES: SCLC makes up approximately 15% of all lung carcinomas and is characterized by relatively aggressive spread and poorer prognosis compared to other lung cancers. Treatment options are limited, and their efficacy in randomized trials is poor, whilst outcomes in clinical practice remain unc...
Autores principales: | Povsic, Manca, Enstone, Ashley, Wyn, Robin, Kornalska, Klaudia, Penrod, John R., Yuan, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6638917/ https://www.ncbi.nlm.nih.gov/pubmed/31318909 http://dx.doi.org/10.1371/journal.pone.0219622 |
Ejemplares similares
-
The Economic Burden of Small Cell Lung Cancer: A Systematic Review of the Literature
por: Enstone, Ashley, et al.
Publicado: (2017) -
The Humanistic Burden of Small Cell Lung Cancer (SCLC): A Systematic Review of Health-Related Quality of Life (HRQoL) Literature
por: Bennett, Bryan M., et al.
Publicado: (2017) -
Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
por: Park, Cheol-Kyu, et al.
Publicado: (2019) -
Real-world use of ceftolozane/tazobactam: a systematic literature review
por: Puzniak, Laura, et al.
Publicado: (2021) -
Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections
por: Puzniak, Laura, et al.
Publicado: (2021)